Blindness News and Research

RSS

New gene therapy for wet age-related macular degeneration is on the horizon

Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks.

11 Oct 2019

Study pinpoints a gene that allows chlamydia to pick up DNA from host environment

According to the Centers for Disease Control and Prevention, chlamydia trachomatis is the most commonly reported sexually transmitted bacterial disease in the U.S., totaling 1.7 million cases in 2017. Rates are highest among teenagers and young adults. Left untreated, chlamydia can cause blindness and sterility.

10 Oct 2019

World Report on Vision highlights urgent need for sustainable global outreach efforts

Staggering new statistics released by the World Health Organization in its first World Report on Vision estimate more than 1 billion people are visually impaired because they don't get the care they need - a finding that brings renewed urgency for sustainable global outreach efforts.

10 Oct 2019

WHO’S first world report on vision

Vision is the most compelling contributor to the quality of our senses, and yet eye care lags behind many other areas in the importance it commands in public health. The World Health Organization (WHO) has said, in its report timed for World Sight Day (October 10), that over 2.2 billion people around the world (out of a total of 7.7 billion) are blind, completely or partially.

9 Oct 2019

Report: Aging populations, changing lifestyles are main drivers of vision impairment

More than 1 billion people worldwide are living with vision impairment because they do not get the care they need for conditions like short and far sightedness, glaucoma, diabetes, and cataracts, according to the first-ever World Report on Vision issued by the World Health Organization.

9 Oct 2019

Congenital syphilis continues to rise at an alarming rate

One of the nation's most preventable diseases is killing newborns in ever-increasing numbers.

8 Oct 2019

Federally funded Obria prescribes abstinence to stop the spread of STDs

Inside Obria Medical Clinics, conviction — not condoms — is summoned to stop the spread of chlamydia.

7 Oct 2019

Even diet drinks increase the risk of type 2 diabetes, finds study

Drinking more than two artificially sweetened or sugary soft drinks each day may increase the risk of diabetes, say Harvard researchers.

4 Oct 2019

Low-income people enrolled in expanded Medicaid program have undiagnosed chronic illness

Nearly one in three low-income people who enrolled in Michigan's expanded Medicaid program discovered they had a chronic illness that had never been diagnosed before, according to a new study.

1 Oct 2019

New CRISPR-Cas9 variant has potential to increase precision during gene therapy

Researchers have developed a new variant of the gene editing technique CRISPR-Cas9 that has the potential to increase precision during gene therapy in humans.

30 Sep 2019

Researchers shed new light on how Toxoplasma parasite damages the human eye

One third of the world population is infected with the parasite -Toxoplasma- which causes a common eye infection called ocular toxoplasmosis. Researchers have shed new light on how an infection with the parasite causes a distinctive lesion in the retina.

30 Sep 2019

Study shows possibility of diabetes remission with ‘achievable’ weight loss

People who achieve weight loss of 10% or more in the first five years following diagnosis with type 2 diabetes have the greatest chance of seeing their disease go into remission, according to a study led by the University of Cambridge.

30 Sep 2019

New study on gene modulation may help prevent blindness

Genes borrowed from a spider turned Peter Parker into Spiderman. If scientists can use archaea--tiny organisms similar to bacteria--as a source of useful genes for humans, might it help prevent blindness one day?

27 Sep 2019

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.

26 Sep 2019

Inflammasome, Boehringer Ingelheim team up to develop new therapies for retinal diseases

Boehringer Ingelheim and Inflammasome Therapeutics Inc. (Inflammasome) today announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal diseases.

From Boehringer Ingelheim International GmbH 25 Sep 2019

7-year-old treated with FDA-approved gene therapy for Leber congenital amaurosis

When Zion Grant was 3 months old his mother Daisy Dodd noticed he wasn't tracking her with his eyes. Zion would fixate on a light in the room, but not on her face.

24 Sep 2019

African bacterium resists almost all drugs

It looks like it’s time to pay the piper. The first extensively drug-resistant (XDR) strain of Salmonella typhimurium, called ST313 sublineage II.1, has cropped up in the Democratic Republic of Congo (DRC). This fails to respond to any of the antibiotics that are commonly used in the DRC, except for ciprofloxacin. And to make things worse, one sample has been isolated that shows incomplete response even to this last drug.

22 Sep 2019

New study identifies potential enzyme target for diabetic retinopathy

A new study shows that diabetic retinopathy (DR), or retinal disease caused by the high blood glucose levels in diabetes mellitus, is due to the death of retinal cells because of the high levels of a pro-enzyme called lysyl oxidase propeptide (LOX-PP). This could help researchers develop specific treatments by targeting this molecule.

22 Sep 2019

Researchers discover potential approach to treating diabetic retinopathy

Boston University researchers have identified an enzymatic precursor that is toxic to retinal cells and could be used in new treatments for diabetic retinopathy.

20 Sep 2019

Researchers find potential new treatment for diabetic retinopathy

About one in three diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness.

19 Sep 2019

Blindness News and Research

New gene therapy for wet age-related macular degeneration is on the horizon

Study pinpoints a gene that allows chlamydia to pick up DNA from host environment

World Report on Vision highlights urgent need for sustainable global outreach efforts

WHO’S first world report on vision

Report: Aging populations, changing lifestyles are main drivers of vision impairment

Congenital syphilis continues to rise at an alarming rate

Federally funded Obria prescribes abstinence to stop the spread of STDs

Even diet drinks increase the risk of type 2 diabetes, finds study

Low-income people enrolled in expanded Medicaid program have undiagnosed chronic illness

New CRISPR-Cas9 variant has potential to increase precision during gene therapy

Researchers shed new light on how Toxoplasma parasite damages the human eye

Study shows possibility of diabetes remission with ‘achievable’ weight loss

New study on gene modulation may help prevent blindness

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Inflammasome, Boehringer Ingelheim team up to develop new therapies for retinal diseases

7-year-old treated with FDA-approved gene therapy for Leber congenital amaurosis

African bacterium resists almost all drugs

New study identifies potential enzyme target for diabetic retinopathy

Researchers discover potential approach to treating diabetic retinopathy

Researchers find potential new treatment for diabetic retinopathy

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News